According to Jarry, The Huberman Lab podcast has been sponsored by "companies offering questionable products from the perspective of science-based medicine", including AG1 (formerly Athletic Greens)
Rodent models demonstrated significant reductions in body weight and food intake via triple-receptor activation (Coskun et al., 2022) Animal studies showed improved glycemic control and lipid metabolism markers (Eli Lilly preclinical data, 2022) Mouse models observed enhanced energy expenditure compared to single- and dual-agonist controls Shipping & returns Processed within 12 business days
RFDiffusion3 and Atomic-Level Constraint Specification The release of RFDiffusion3 in late 2025 has enabled the design of binders for specific epitopes with unprecedented precision
Tolerability though safe and taken by millions of people, GLP-1s still leave more to be desired from tolerability with troublesome gastrointestinal side effects
However, high cost of treatment and growing competition from non-pharmacological approaches might slow down market growth to some extent during the forecast period
The sustained success of Jardiance underscores the strategic value of the Boehringer-Lilly partnership and the drugs expanding role in managing cardiometabolic diseases
